Nuvectis Pharma (NVCT) stock Forecast for 2022 – 2026

Nuvectis Pharma (NVCT) stock Forecast for 2022 – 2026

Last update: December 3, 2022 (06:25)

Sector: Healthcare

The share price of Nuvectis Pharma, Inc. (NVCT) now

What analysts predict: $20.67

52-week high/low: $20.92 / $3.08

50/200 Day Moving Average: $7.14 / $9.41

This figure corresponds to the average price over the previous 50/200 days. For Nuvectis Pharma stocks, the 50-day moving average is the support level today.

For Nuvectis Pharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Nuvectis Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nuvectis Pharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Nuvectis Pharma share be worth in 2022 - 2026?

When should I take profit in Nuvectis Pharma stock? When should I record a loss on Nuvectis Pharma stock? What are analysts' forecasts for Nuvectis Pharma stock? What is the future of Nuvectis Pharma stock? We forecast Nuvectis Pharma stock performance using neural networks based on historical data on Nuvectis Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Nuvectis Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Nuvectis Pharma shares. This happens once a day.




Historical and forecast chart of Nuvectis Pharma stock

The chart below shows the historical price of Nuvectis Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Nuvectis Pharma stock price can be found in the table below.

Long-term forecasts by years.

Nuvectis Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 05 7.86 7.74 8.19 5.79
Dec 06 8.00 7.65 8.30 8.47
Dec 07 7.65 7.41 7.90 6.63
Dec 08 7.75 7.47 7.89 5.66
Dec 09 7.55 7.30 7.83 7.20
Dec 10 7.35 7.07 7.52 6.36
Dec 11 7.37 7.10 7.64 7.60
Dec 12 7.56 7.22 7.80 7.91
Dec 13 7.26 7.02 7.48 6.51
Dec 14 6.94 6.79 7.15 5.33
Dec 15 7.04 6.80 7.34 7.95
Dec 16 7.34 7.10 7.55 6.45
Dec 17 7.20 6.94 7.53 8.40
Dec 18 7.03 6.77 7.21 6.54
Dec 19 6.98 6.67 7.16 7.35
Dec 20 6.90 6.72 7.06 5.12
Dec 21 7.16 6.88 7.44 8.18
Dec 22 7.25 6.91 7.40 7.11
Dec 23 7.29 6.99 7.52 7.57
Dec 24 6.93 6.71 7.04 4.89
Dec 25 6.99 6.82 7.24 6.28
Dec 26 6.67 6.54 6.78 3.67
Dec 27 6.94 6.71 7.03 4.71
Dec 28 6.80 6.71 7.04 4.92
Dec 29 6.63 6.54 6.91 5.60
Dec 30 6.61 6.31 6.79 7.67
Dec 31 6.60 6.32 6.76 6.95
Jan 01 6.64 6.35 6.90 8.52
Jan 02 6.25 6.04 6.41 6.08
Jan 03 5.97 5.90 6.17 4.55

Nuvectis Pharma Daily Price Targets


Nuvectis Pharma Stock Forecast 12-05-2022.

Forecast target price for 12-05-2022: $7.86.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.473%.
Pessimistic target level: 7.74
Optimistic target level: 8.19

Nuvectis Pharma Stock Forecast 12-06-2022.

Forecast target price for 12-06-2022: $8.00.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 7.805%.
Pessimistic target level: 7.65
Optimistic target level: 8.30

Nuvectis Pharma Stock Forecast 12-07-2022.

Forecast target price for 12-07-2022: $7.65.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.219%.
Pessimistic target level: 7.41
Optimistic target level: 7.90

Nuvectis Pharma Stock Forecast 12-08-2022.

Forecast target price for 12-08-2022: $7.75.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.360%.
Pessimistic target level: 7.47
Optimistic target level: 7.89

Nuvectis Pharma Stock Forecast 12-09-2022.

Forecast target price for 12-09-2022: $7.55.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.714%.
Pessimistic target level: 7.30
Optimistic target level: 7.83

Nuvectis Pharma Stock Forecast 12-10-2022.

Forecast target price for 12-10-2022: $7.35.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.977%.
Pessimistic target level: 7.07
Optimistic target level: 7.52

NVCT (NVCT) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 6.66 6.22 7.57 17.78

Nuvectis Pharma forecast for this year


Nuvectis Pharma Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $6.6646. Pessimistic: $6.22. Optimistic: $7.57



Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 7.30 6.15 7.70 20.11
Mar 8.01 6.76 8.55 20.97
Mar 7.75 6.65 8.51 21.86
Apr 7.44 6.83 8.27 17.45
May 7.29 6.69 7.82 14.37
Jun 7.52 6.53 7.95 17.80
Jul 8.07 7.37 8.69 15.21
Aug 7.84 6.91 8.23 16.00
Sep 8.51 7.78 9.79 20.52
Oct 9.31 7.84 10.17 22.89
Nov 9.80 8.37 10.99 23.89
Dec 10.60 9.54 11.32 15.73

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 12.62 11.61 13.55 14.34
Feb 14.31 13.53 14.91 9.21
Mar 14.48 13.12 16.36 19.82
Apr 16.85 14.80 17.90 17.33
May 18.40 15.75 20.91 24.65
Jun 17.41 16.47 18.77 12.25
Jul 17.27 15.23 19.00 19.82
Aug 18.51 17.03 19.85 14.18
Sep 17.11 14.99 18.00 16.73
Oct 17.14 14.84 19.88 25.34
Nov 17.96 15.20 20.73 26.69
Dec 18.36 16.52 20.49 19.35

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 18.29 16.57 20.44 18.96
Mar 17.63 15.41 19.46 20.83
Mar 19.00 17.79 20.79 14.44
Apr 17.63 15.48 18.66 17.01
May 17.18 16.15 18.86 14.39
Jun 14.12 12.51 15.98 21.73
Jul 14.15 12.03 15.73 23.56
Aug 13.92 11.69 15.28 23.50
Sep 15.12 13.76 15.78 12.84
Oct 17.14 16.42 17.90 8.24
Nov 20.16 18.02 21.65 16.76
Dec 18.63 17.62 19.75 10.75

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 19.30 17.45 22.16 21.25
Mar 22.85 20.20 25.87 21.91
Mar 22.67 19.40 25.21 23.02
Apr 19.40 18.51 21.73 14.82
May 18.82 17.54 21.04 16.64
Jun 19.91 17.92 21.63 17.13
Jul 20.83 17.91 23.00 22.10
Aug 22.62 19.27 25.06 23.10
Sep 24.20 22.41 28.03 20.03
Oct 24.74 21.52 27.80 22.60
Nov 24.98 23.83 27.28 12.64
Dec 29.48 26.89 33.49 19.72

Nuvectis Pharma information and performance

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Nuvectis Pharma Address

1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, UNITED STATES

Market Capitalization: 106 451 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.832

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.63

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 14642500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.